MARAVAI LIFESCIENCES HLDGS I's ticker is MRVI and the CUSIP is 56600D107. A total of 221 filers reported holding MARAVAI LIFESCIENCES HLDGS I in Q4 2023. The put-call ratio across all filers is 0.83 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $225,418 | -15.8% | 31,483 | +2.0% | 0.00% | 0.0% |
| Q1 2024 | $267,721 | +30.4% | 30,879 | -1.5% | 0.00% | 0.0% |
| Q4 2023 | $205,323 | -35.7% | 31,347 | -1.8% | 0.00% | -33.3% |
| Q3 2023 | $319,200 | -18.4% | 31,920 | +1.4% | 0.00% | 0.0% |
| Q2 2023 | $391,098 | -13.8% | 31,464 | -2.9% | 0.00% | -25.0% |
| Q1 2023 | $453,882 | +0.5% | 32,397 | +2.7% | 0.00% | 0.0% |
| Q4 2022 | $451,466 | -41.8% | 31,549 | +3.8% | 0.00% | -50.0% |
| Q3 2022 | $776,000 | -9.8% | 30,384 | +0.3% | 0.01% | 0.0% |
| Q2 2022 | $860,000 | -19.2% | 30,282 | +0.3% | 0.01% | -11.1% |
| Q1 2022 | $1,065,000 | -15.5% | 30,205 | +0.5% | 0.01% | -10.0% |
| Q4 2021 | $1,260,000 | -15.6% | 30,066 | -1.1% | 0.01% | -16.7% |
| Q3 2021 | $1,493,000 | +46.9% | 30,413 | +24.9% | 0.01% | +50.0% |
| Q2 2021 | $1,016,000 | – | 24,358 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GTCR LLC | 21,681,033 | $269,495,240 | 12.63% |
| 12 West Capital Management LP | 3,361,836 | $41,787,621 | 3.59% |
| Alpine Peaks Capital, LP | 329,424 | $4,094,740 | 2.87% |
| Roubaix Capital, LLC | 235,480 | $2,927,016 | 2.15% |
| Prosight Management, LP | 628,600 | $7,813,498 | 1.17% |
| Cannon Global Investment Management, LLC | 15,800 | $196,394 | 1.02% |
| Curi Wealth Management, LLC | 566,417 | $7,040,564 | 0.95% |
| Mesirow Institutional Investment Management, Inc. | 693,376 | $8,618,664 | 0.89% |
| BRAIDWELL LP | 1,804,700 | $22,432,421 | 0.73% |
| Connacht Asset Management LP | 39,031 | $485,155 | 0.66% |